Did You Invest in Cardiac Network Promissory Notes?

Soreide Law Group, PLLC, is currently investigating the sale of promissory notes to investors by their brokerages.  Again, many conservative investors have said they were sold these notes as "low risk" when in fact, they were highly risky or fraudulent.  These investments also paid significantly higher fees to the brokers, making them much more motivated to sell them to their clients.

Cardiac Network, Inc., with the HeartOne Monitoring Stystem, a medical technology company providing cardiac monitoring to physicians, allegedly is one of those companies. Apparently, some brokers have allegedly been selling promissory notes without getting approval for their sale.  According to the FINRA Rules, this would constitute, 'selling away.'  These notes now, could be worthless.

Securities Lawyer, Lars K. Soreide, of Soreide Law Group, PLLC, has represented clients nationwide. If you or a family member have sustained investment losses due to your stock broker or financial advisor’s recommendations of Cardiac Network Promissory Notes, call for a free consultation on how to potentially recover your losses. To speak with an attorney call 888-760-6552, or visit our website at: www.securitieslawyer.com.

Soreide Law Group, PLLC., representing investors nationwide before FINRA the Financial Industry Regulatory Authority.